ALLO·019770106·US·equity·Healthcare - Biotechnology-Activist
ALLO (ALLOGENE THERAPEUTICS INC) is held by 114 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($46.6M), STATE STREET CORP ($21.1M), PRIMECAP MANAGEMENT CO/CA/ ($20.4M). Net institutional sentiment: Bullish.
See how ALLO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer